Peritumoral TNFα administration influences tumour stroma structure and physiology independently of growth in DMBA‐induced mammary tumours

References

• Heldin N. E., Rubin K., Pietras K., Östman A. High interstitial fluid pressure – an obstacle in cancer therapy. Nat Rev 2004; 4: 806–13
   Google Scholar
• Pietras K., Østman A., Sjoquist M., Buchdunger E., Reed R. K., Heldin C. H., et al. Inhibition of platelet‐derived growth factor receptor reduces interstitial hypertension and increases transcapillary transport in tumors. Cancer Res 2001; 61: 2929–34
   PubMed Web of Science ®Google Scholar
• Jain R. K. Transport of molecules in the tumor interstitium: a review. Cancer Res 1987; 47: 3039–51
   PubMed Web of Science ®Google Scholar
• Emerich D. F., Dean R. L., Snodgrass P., Lafreniere D., Agostino M., Wiens T., et al. Bradykinin modulation of tumor vasculature: II. Activation of nitric oxide and phospholipase A2/prostaglandin signaling pathways synergistically modifies vascular physiology and morphology to enhance delivery of chemotherapeutic agents to tumors. J Pharmacol Exp Ther 2001; 296: 632–41
   PubMedGoogle Scholar
• Salnikov A. V., Iversen V. V., Koisti M., Sundberg C., Johansson L., Stuhr L. B., et al. Lowering of tumor interstitial fluid pressure specifically augments efficacy of chemotherapy. Interference with TGF‐beta1 and ‐beta3 in tumor stroma lowers tumor interstitial fluid pressure independently of growth in experimental carcinoma. Faseb J 2003; 17: 1756–8
   PubMed Web of Science ®Google Scholar
• Pollard J. W. Tumour‐educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004; 4: 71–8
   PubMed Web of Science ®Google Scholar
• Salnikov A. V., Roswall P., Sundberg C., Gardner H., Heldin N. E., Rubin K. Inhibition of TGF‐beta modulates macrophages and vessel maturation in parallel to a lowering of interstitial fluid pressure in experimental carcinoma. Lab Invest 2005; 85: 512–21
   PubMedGoogle Scholar
• Brekken R. A., Sage E. H. SPARC, a matricellular protein: at the crossroads of cell matrix. Matrix Biol 2000; 19: 569–80
   PubMed Web of Science ®Google Scholar
• Netti P. A., Berk D. A., Swartz M. A., Grodzinsky A. J., Jain R. K. Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res 2000; 60: 2497–503
   PubMed Web of Science ®Google Scholar
• Brown E., McKee T., diTomaso E., Pluen A., Seed B., Boucher Y., et al. Dynamic imaging of collagen and its modulation in tumors in vivo using second‐harmonic generation. Nat Med 2003; 9: 796–800
   PubMed Web of Science ®Google Scholar
• McKee T. D., Grandi P., Mok W., Alexandrakis G., Insin N., Zimmer J. P., et al. Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector. Cancer Res 2006; 66: 2509–13
   PubMed Web of Science ®Google Scholar
• Oldberg A., Kalamajski S., Salnikov A. V., Stuhr L., Mogelin M., Reed R. K., et al. Collagen‐binding proteoglycan fibromodulin can determine stroma matrix structure and fluid balance in experimental carcinoma. PNAS 2007; 104: 13966–71
   PubMedGoogle Scholar
• Nedrebø T., Berg A., Reed R. K. Effect of tumor necrosis factor‐α, IL‐1β, and IL‐6 on interstitial fluid pressure in rat skin. Am J Physiol Heart Circ Physiol 1999; 277: 1857–62
   PubMed Web of Science ®Google Scholar
• Kristensen C. A., Nozue M., Boucher Y., Jain R. K. Reduction of interstitial fluid pressure after TNF‐α treatment of three human melanoma xenografts. Br J Cancer 1996; 74: 533–6
   PubMed Web of Science ®Google Scholar
• Lejeun F. J., Ruegg C., Lienard D. Clinical applications of TNF‐alpha in cancer. Curr Poin Immunol 1998; 10: 573–80
   PubMedGoogle Scholar
• Szlosarek P. W., Balkwill R. Tumour necrosis factor α: a potential target for the therapy of solid tumours. Lancet Oncol 2003; 4: 565–73
   PubMed Web of Science ®Google Scholar
• Eggermont A. M., deWilt J. H., tenHagen T. L. Current uses of isolated limb perfusion in the clinic and a model system for new stragegies. Lancet Oncol 2003; 4: 429–37
   PubMed Web of Science ®Google Scholar
• Havell E. A., Fiers W., North R. J. The anti‐tumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity. J Exp Med 1988; 167: 1067–85
   PubMed Web of Science ®Google Scholar
• Moore R. J., Owens D. M., Stamp G., Arnott C., Burke F., et al. Mice deficient in tumor necrosis factor‐alpha are resistant to skin carcinogenesis. Mat Med 1999; 5: 828–31
   Google Scholar
• Suganuma M., Okabe S., Marino M. W., Sakai A., Sueoka E., Fujiki H. Essential role of tumor necrosis factor alpha (TNF‐alpha) in tumor promotion as revealed by TNF‐alpha‐deficient mice. Cancer Res 1999; 59: 4516–18
   PubMed Web of Science ®Google Scholar
• Baxevanis C. N., Voutsas I. F., Tsitsilonis O. E., Tsiatas M. L., Gritzapis A. D., Papamichail M. Compromised anti‐tumor responses in tumor necrosis factor‐alpha knockout mice. Eur J Immunol 2000; 30: 1957–66
   PubMedGoogle Scholar
• Balkwill A. S. Control of oncogenesis and cancer therapy resistance by the transcription factor NF‐kappaB. J Clin Invest 2001; 107: 241–6
   PubMedGoogle Scholar
• Kitakata H., Nemoto‐Sasaki Y., Takahashi Y., Kondo T., Mai M., Mukaisa N. Essential roles of tumor necrosis factor receptor p55 in liver metastasis of intrasplenic administration of colon 26 cells. Cancer Res 2002; 26: 6682–7
   Google Scholar
• Fadnes H. O., Reed R. K., Aukland K. Interstitial fluid pressure in rats measured with a modified wick technique. Microvasc Res 1977; 14: 27–36
   PubMed Web of Science ®Google Scholar
• Wiig H., Aukland K., Tenstad O. Isolation of interstitial fluid from rat mammary tumors by a centrifugation method. Am J Physiol Heart Circ Physiol 2003; 284: 416–24
   PubMed Web of Science ®Google Scholar
• Sundberg C., Ivarsson M., Gerdin B., Rubin K. Pericytes as collagen‐producing cells in excessive dermal scarring. Lab Invest 1996; 74: 452–66
   PubMedGoogle Scholar
• Svendsson L., Aszodi A., Reinholdt F. P., Fassler R., Heinegård D., Oldberg Å. Fibromodulin‐null mice have abnormal collagen fibrils, tissue organization, and altered lumican deposition in tendon. J Biol Chem 1999; 274: 9636–47
   PubMedGoogle Scholar
• Wiig H. Microvascular pressures in DMBA‐induced rat mammary tumors. Scand J Clin Lab Invest 1982; 42: 165–71
   PubMedGoogle Scholar
• Stuhr L. E. B., Salnikov A. V., Iversen V. V., Salvesen G., Rubin K., Reed R. K. High‐dose, short‐term, anti‐inflammatory treatment with dexamethasone reduces growth and augments the effects of 5‐fluorouracil on dimethyl‐alpha‐benzanthracene‐induced mammary tumors in rats. Scand J Clin Lab Invest 2006; 66: 477–86
   PubMed Web of Science ®Google Scholar
• Aukland K., Reed R. K. Interstitial‐lymphatic mechanisms in the control of extracellular fluid volume. Physiol Rev 1993; 73: 1–78
   PubMed Web of Science ®Google Scholar
• Wiig H., Rubin K., Reed R. K., Tveit E., Hultborn R., Weiss L. New and active role of the interstitium in control of interstitial fluid pressure: potential therapeutic consequences. Evaluation of methodologies for measurement of interstitial fluid pressure (Pif): physiological implications of recent Pi data. Interstitial fluid pressure in DMBA‐induced rat mammary tumours. Acta Anaesthesiol Scand 2003; 47: 111–21
   PubMed Web of Science ®Google Scholar
• Rippe B., Haraldsson B. Transport of macromolecules across microvascular walls: the two‐pore theory. Physiol Rev 1994; 74: 163–219
   PubMed Web of Science ®Google Scholar
• Vaupel P., Kallinowski F., Okunieff P. Blood flow, oxygen and nutrient supply, and microenvironment of human tumors, a review. Cancer Res 1989; 49: 6449–65
   PubMed Web of Science ®Google Scholar
• Lammerts E., Roswall P., Sundberg C., Gotwals P. J., Koteliansky V. E., Reed R. K., et al. Interference with TGF‐beta1 and ‐beta3 in tumor stroma lowers tumor interstitial fluid pressure independently of growth in experimental carcinoma. Int J Cancer 2002; 102: 453–62
   PubMedGoogle Scholar
• Lee C‐G., Heijn M., di Tomaso E., Griffon‐Etienne G., Ancukiewich M., Koike C., et al. Anti‐vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Res 2000; 60: 5565–70
   PubMed Web of Science ®Google Scholar
• Bingle L., Brown N. J., Lewis C. E. The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 2002; 196: 254–65
   PubMed Web of Science ®Google Scholar